General Information of the Compound
| Compound ID |
CP0121940
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
DdC
1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine
2',3'-DIDEOXYCYTIDINE
2',3'-Dideoxycytidine & Interferon-alpha
2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate)
2',3'-Dideoxycytidine & sCD4(soluble recombinant protein)
2,3-dideoxycytidine
3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine
4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
6L3XT8CB3I
7481-89-2
BRN 0654956
Beta-D-2',3'-Dideoxycytidine
Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor
Beta-D-DDC
C9H13N3O3
CCRIS 692
CHEBI:10101
CHEMBL853
Cytidine, 2',3'-dideoxy & Interferon alpha
Cytidine, 2',3'-dideoxy-
Cytidine, 2',3'-dideoxy-& Colony-stimulating factor
D 5782
DDC (DDC)
DS-4152 & ddC
DdC
DdC & GM-CSF
DdC & IFN-alpha
DdC & Interferon alpha
DdC & NP (from PHCA or HSA)
DdC & sCD4
DdC (Antiviral)
DdCyd
Dideoxycytidine
HIVID
HSDB 7156
Hivid (TN)
Hivid(TM)
Hivid, Dideoxycytidine, NSC 606170, Zalcitabine
Interferon AD + ddC
KS-1130
Lecithinized superoxide dismutase & beta-D-2',3'-Dideoxycytidine
MFCD00012188
NSC 606170
PC-SOD & ddC
Ro 24-2027/000
Ro-24-2027/000
SRI-7707
Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine
UNII-6L3XT8CB3I
WREGKURFCTUGRC-POYBYMJQSA-N
Zalcitabine
Zalcitabine (JAN/USP/INN)
Zalcitabine [USAN:INN:BAN]
Zalcitibine
ddC
ddCyd
zalcitabine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H13N3O3
|
||||||||||||||||||
| Molecular Weight |
211.221
|
||||||||||||||||||
| Canonical SMILES |
Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WREGKURFCTUGRC-POYBYMJQSA-N
|
||||||||||||||||||
| CAS |
7481-89-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02059, C-X-C chemokine receptor type 4
Protein ID: PT06109, Geminin
Protein ID: PT00005, Reverse transcriptase/RNaseH
Protein ID: PT06206, Solute carrier family 22 member 7
Clinical Information about the Compound